Jim Cramer: Wednesday Is a Watershed Day for Cannabis Stocks

But don't buy into this overheated market right as Canada legalizes, wait until prices come down -- which they will.

Stock Pickers Soon Should Find Values Amid Fear-Stoked Wreckage

Big-picture concerns are intensifying selling pressure, which favors bargain hunters in search of individual stocks.

Jim Cramer: This Selloff Is Driven By Naked Fear

But it also creates opportunities. Here is how to play it.

Jim Cramer: This Is What Larry Culp Must Do to Get GE Back in Action

The problems at GE are all about hubris and hurt feelings.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

A Brief Bird's Eye View of Fresh IPO Elanco Animal Health

The limited technical data for the recent Eli Lilly spinoff indicate buyers came in early and appear to be holding.

Jim Cramer: The Tilray Short Squeeze

Cannabis companies should be taking advantage of the mania to raise money.

Synchrony, Exelixis Look Like Good Values

The credit card provider and the biotech concern appear cheap relative to their potential.

Profit by Focusing on Net Profit Margins

The key business statistic can be quite predictive about what's likely to occur with a stock's price.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.